comparemela.com

Latest Breaking News On - Niti aayog member - Page 10 : comparemela.com

US declines emergency use clearance for Covaxin

1062 New Delhi, June 11 The US drug regulator FDA today declined emergency use authorisation to Bharat Biotech-made Covaxin, asking the Hyderabad-based firm to pursue full approval pathway. Bharat Biotech said it would pursue the FDA’s advice for full approval, which, when granted to Covaxin, would be the first for any Indian vaccine manufacturer. Heart inflammation post Pfizer, Moderna shot? A top US disease control agency is reviewing reports of heart inflammation in male teens, young adults after Pfizer and Moderna 2nd dose. Virbhadra tests +ve 2nd time in 2 months After testing Covid positive on April 12, HP ex-CM Virbhadra Singh again tested positive on Friday.

Centre to ramp up paediatric infrastructure as Covid cases dip to two-month low

924 New Delhi, June 6 The daily Covid-19 cases fell to a two-month low of 1.14 lakh on Sunday, with active cases dropping below 15 lakh in a consistently receding second wave. The official data shows a steady rise in national recovery rate at 93.67 per cent and the daily positivity rate falling to 5.62 per cent with the infection rate staying below 10 per cent for 13 days now. The toll climbed to 3,46,759 with 2,677 deaths in the past 24 hours, the lowest in nearly 42 days. Story Highlights TOTAL DEATHS 3,46,759 ACTIVE CASES 14,77,799 2,677 deaths in 24 hours   The Health Ministry said 1,14,460 new cases were the lowest in the past two months. The country has recorded less than 2 lakh daily cases for 10 consecutive days. After a net decline of 77,449 cases today, active cases stand at 5.13 per cent of the total. The cumulative number of vaccine doses administered in the country exceeded 23 crore today. The government is now planning to ramp up paediatric Covid facilities t

Second COVID-19 wave will not impact India s agri sector in any way: Niti Aayog

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.